Acciones de Tempus AI hoy: rentabilidad y valor bursátil de la acción. Consulte la cotización de Tempus AI en bolsa (NASDAQ:TEM) y su último precio: 68,34.

The European Commission has approved Eisai and Biogen's Leqembi for a subset of patients with early-stage Alzheimer's disease, setting it up to become the first amyloid-targeting drug to reach the ...